Position in SHC
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$5,898,591
+$2,989,264 QoQ
Shares Held
332,315
+63.8% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#66
of 319 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $665,369,236 across 21 Diagnostics & Research names. SHC ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
526,918 | $264,175,606 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
563,844 | $108,945,936 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
145,168 | $76,422,240 | |
| 4 | A |
Agilent Technologies, Inc.
|
400,557 | $53,205,984 | |
| 5 | LH |
Labcorp Holdings Inc.
|
128,335 | $35,933,800 | |
| 6 | CSTL |
Castle Biosciences Inc
|
879,258 | $20,970,302 | |
| 7 | GH |
Guardant Health, Inc.
|
109,240 | $16,389,277 | |
| 8 | DHR |
Danaher Corp /De/
|
65,286 | $12,435,677 |
All Filings in SHC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,898,591 | 332,315 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $2,909,327 | 202,882 | Shares | Defined | 2026-05-11 | |
| 2024-03-31 | $203,365 | 16,933 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,229,929 | 132,340 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,902,130 | 126,978 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,594,324 | 137,703 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,466,260 | 137,703 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,163,633 | 379,788 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $991,055 | 145,316 | Shares | Defined | 2022-11-08 | |
| No filing history on record for this holder in this stock. | ||||||